Clinical Trials Browser

Recruiting × Interventional × Adenocarcinoma of Lung × Clear all

NCT04937283 2026-04-13

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Phase NA Recruiting

Adenocarcinoma of Lung

NCT05198830 2026-04-13

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT05764954 2026-04-09

A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma

Phase 1 Recruiting

Adenocarcinoma of Lung

NCT07090499 2026-04-07

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Phase 1 Recruiting

GastrointestinalGenitourinaryHead & NeckThoracic

Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Pancreatic Neoplasms

NCT06495125 2026-04-06

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT07481786 2026-04-06

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Phase 3 Recruiting

Adenocarcinoma of Lung, Brain Neoplasms

NCT07479095 2026-03-20

KETO-FDG Lung

Phase NA Recruiting

Adenocarcinoma of Lung

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Phase 1 Recruiting

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT07219251 2026-03-03

EVLC

Phase NA Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT05797168 2026-03-02

FONTANA

Phase 1/2 Recruiting

GynecologicThoracic

Adenocarcinoma of Lung, Ovarian Neoplasms, Endometrial Neoplasms

NCT07423169 2026-02-20

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer

Phase NA Recruiting

Adenocarcinoma of Lung

NCT03199651 2026-02-19

BLCIO

Phase NA Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT07235280 2026-02-19

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Phase EARLY_PHASE1 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT04485013 2026-02-18

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Phase 1 Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04339218 2026-01-30

CRYOMUNE

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT05456256 2025-11-20

HARMONIC

Phase 2 Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05887492 2025-11-18

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Phase 1/2 Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05558904 2025-11-10

An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

Phase 1/2 Recruiting

Adenocarcinoma of Lung

NCT07116057 2025-10-10

MOv19-BBz CAR T Cells in FRa+ Cancers

Phase 1 Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07161713 2025-09-23

RESET

Phase NA Recruiting

GastrointestinalThoracic

Adenocarcinoma of Lung, Colonic Neoplasms, Disease, Lung Neoplasms

NCT04105270 2025-09-11

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT06796816 2025-01-28

BIVA-18

Phase NA Recruiting

Adenocarcinoma of Lung, Lung Neoplasms, Sarcopenia

NCT06634966 2024-10-10

Segmentectomy for Solid-dominant Lung Cancer

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT06528847 2024-07-31

Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT05717803 2024-06-03

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT05266846 2024-05-30

BEYOND

Phase 2 Recruiting

Adenocarcinoma of Lung

NCT05528458 2024-04-23

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma of Lung

NCT06031181 2023-12-13

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT06056115 2023-09-28

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Phase NA Recruiting

Adenocarcinoma of Lung

NCT06031246 2023-09-11

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

Phase 3 Recruiting

Adenocarcinoma of Lung, Lymphatic Metastasis

NCT05733000 2023-03-10

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Phase 2 Recruiting

GastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma of Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05503667 2022-08-17

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma of Lung

NCT03351842 2017-12-19

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Phase 2 Recruiting

Adenocarcinoma of Lung, Neoplasms by Histologic Type